Iradimed Corp
IRMD- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001325618
In the last 90 days, Iradimed Corp insiders filed 0 open-market purchases and 1 sale; 213 institutions reported holding it in 13F filings for Q2 2026, worth $750.4M in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $122.6K in total
- 1
- 13F holdersQ2 2026, −11 vs. previous quarter
- 213
- 13F valueReported value at the end of Q2 2026
- $750.4M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding IRMD, Q2 2026
No superinvestor reported holding IRMD at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Iradimed Corp insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 8, 2026 (view filing)4:35 PM ET | Sep 3 | 5 days | Allen Monty KDirector | SSale | −1.42K | $86.41 | −$122.6K | −6.8%19.6K after | 2 lots |
| Jun 4, 2026 (view filing) | Jun 4 | Same day | Scharen-Guivel Hilda FrederiqueDirector | SSale | −3.00K | $95.00 | −$285.0K | −34.9%5.60K after | 2 lots |
| Jun 2, 2026 (view filing) | Jun 1 | 1 day | Susi Roger E.CEO, President, Chairman | SSale | −2.50K | $90.60 | −$226.5K | −0.1%2.16M after | 4 lots10b5-1 |
| May 28, 2026 (view filing) | May 26-27 | 2 days | Susi Roger E.CEO, President, Chairman | SSale | −7.50K | $92.14 | −$691.0K | −0.3%2.17M after | 4 lots10b5-1 |
| May 20, 2026 (view filing) | May 18-19 | 2 days | Susi Roger E.CEO, President, Chairman | SSale | −7.50K | $87.64 | −$657.3K | −0.3%2.17M after | 6 lots10b5-1 |
| May 13, 2026 (view filing) | May 11-12 | 2 days | Susi Roger E.CEO, President, Chairman | SSale | −7.50K | $84.18 | −$631.3K | −0.3%2.18M after | 5 lots10b5-1 |
| May 6, 2026 (view filing) | May 4-5 | 2 days | Susi Roger E.CEO, President, Chairman | SSale | −7.50K | $85.71 | −$642.9K | −0.3%2.19M after | 7 lots10b5-1 |
| Apr 30, 2026 (view filing) | Apr 27-28 | 3 daysLate | Susi Roger E.CEO, President, Chairman | SSale | −7.50K | $87.69 | −$657.7K | −0.3%2.19M after | 7 lots10b5-1 |
| Apr 22, 2026 (view filing) | Apr 20-21 | 2 days | Susi Roger E.CEO, President, Chairman | SSale | −7.50K | $92.55 | −$694.1K | −0.3%2.20M after | 6 lots10b5-1 |
| Apr 15, 2026 (view filing) | Apr 13-14 | 2 days | Susi Roger E.CEO, President, Chairman | SSale | −7.50K | $92.96 | −$697.2K | −0.3%2.21M after | 5 lots10b5-1 |
Top 10 13F holders, Q2 2026
The largest institutional positions in Iradimed Corp at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 967,825 | $92.5M | 0.00% | +380.0% | Added |
| Kayne Anderson Rudnick Investment Management LLC | 396,982 | $37.9M | 0.12% | +47,666+13.6% | Added |
| Renaissance Technologies LLC | 394,412 | $37.7M | 0.05% | −46,300−10.5% | Reduced |
| Copeland Capital Management, LLC | 391,860 | $37.4M | 0.77% | +32,535+9.1% | Added |
| Vanguard Capital Management LLC | 364,937 | $34.9M | 0.00% | +6,317+1.8% | Added |
| T. Rowe Price Investment Management, Inc. | 318,680 | $30.5M | 0.02% | +61,983+24.1% | Added |
| Geode Capital Management, LLC | 290,109 | $27.7M | 0.00% | +3,546+1.2% | Added |
| Nine Ten Capital Management LLC | 256,562 | $24.5M | 7.63% | −77,926−23.3% | Reduced |
| Dimensional Fund Advisors LP | 229,340 | $21.9M | 0.00% | +3,194+1.4% | Added |
| State Street Corp | 221,512 | $21.2M | 0.00% | +16,984+8.3% | Added |